Piper logo Piper logo
Piper logo small
  • About
  • Intellectual Property
  • For Legal Professionals
  • News-Blog
  • Our Services
  • Our People
  • Careers
  • Contact Us
  • Searching
  • Protection
  • Exploitation
  • Enforcement
  • IP Management
  • New Zealand
  • Australia
  • PCT
  • Pipers Bulletins
  • Affiliations
  • IP Articles
  • WorldWide Patent Attorneys
  • Resources
  • Case Studies

Menu

  • About
    • Our Services
    • Our People
    • Careers
    • Contact Us
  • Intellectual Property
    • Searching
    • Protection
    • Exploitation
    • Enforcement
    • IP Management
  • For Legal Professionals
    • New Zealand
    • Australia
    • PCT
    • Pipers Bulletins
    • Affiliations
  • News-Blog
    • IP Articles
    • WorldWide Patent Attorneys
    • Resources
    • Case Studies
News
  • Latest News
  • News Archive
  • Latest News
  • News Archive

IP News to Peruse

Why Identifying the Invention Matters More Than Identifying the Inventor

20th March 2023

The underlying purposes of patent law are best served when the invention has precedence over the inventor.

Read more

Understanding the Concept of an Inventor

20th March 2023

The concept of an inventor needs redefining to specifically include artificial intelligence.

Read more

BOTOX Reputation Unable to Provide Smooth Result for Allergan’s Infringement Allegation

17th March 2023

In Self Care IP Holdings Pty Ltd v Allergan Australia Pty Ltd [2023] HCA 8 the High Court has unanimously allowed Self-Care’s appeal, holding that Allergan’s BOTOX mark has not been infringed either by Self-Care’s use of the phrase "instant Botox® alternative" or by its mark PROTOX.

Read more

Plant Variety Rights Act 2022 Receives Royal Assent

9th December 2022

Following Committee of the Whole House readings the Plant Variety Rights Bill was read a third time on 15th November 2022 and received royal assent as the Plant Variety Rights Act 2022 on 18th November 2022.

Read more

CAFC Finds Eagle Doesn’t Drift Into Par’s Infringement Trap

1st September 2022

In Par Pharmaceutical Inc v Eagle Pharmaceuticals Inc 21-2342 the Court of Appeals for the Federal Circuit (CAFC) affirmed a District Court’s finding that fluctuations in pH levels in a generic composition would not inevitably result in infringement.

Read more

Page 8 of 43 pages ‹ First  < 6 7 8 9 10 >  Last ›